Imaging Analysis for Primary Mitochondrial Medicine

Overview

About this study

The purpose of this study is to further the natural history knowledge about primary mitochondrial diseases through observational imaging techniques, and to assess for indicators of primary mitochondrial diseases through several methods including MRI imaging of the heart and muscles, and through scoring of residual movements from patient recorded videos showing basic home exercise. 

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • Age 15-80 years old.
  • Confirmed primary mitochondrial disorder.

Exclusion Criteria:

  • Pregnant, breastfeeding.
  • Severe cardiac disease.
  • End-stage renal disease.

Exceptions:

  • Allergy to gadolinium will be an exclusion from the cardiac MRI imaging only, the remainder of study actiivtites may still occur and will not be an automatic exclusion.
  • Allergy to regadenoson will be an exclusion from the cardiac stress testing imaging only, the remainder of study activities may still occur and will not be an automatic exclusion.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status

Rochester, Minn.

Mayo Clinic principal investigator

Ralitza Gavrilova, M.D.

Closed for enrollment

More information

Publications

Publications are currently not available

Additional contact information

Non-cancer trials contact form

Phone: 800-664-4542 (toll-free)

International patient clinical studies questions